Capital Fund Management (CFM)
NVAX icon

Capital Fund Management (CFM)’s Novavax NVAX Stock Holding History

Capital Fund Management (CFM)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,900
Closed -$201K – 2409
2025
Q4 		$201K Sell
29,900
-20,600
-41% -$155K ﹤0.01% 2325
2025
Q3 		$438K Sell
50,500
-9,900
-16% -$77K ﹤0.01% 2328
2025
Q2 		$381K Buy
60,400
+4,900
+9% +$32.4K ﹤0.01% 2242
2025
Q1 		$356K Sell
55,500
-4,500
-8% -$37.2K ﹤0.01% 1890
2024
Q4 		$482K Buy
+60,000
New +$578K ﹤0.01% 1916
2023
Q2 		– Sell
-54,900
Closed -$380K – 1831
2023
Q1 		$380K Sell
54,900
-96,100
-64% -$884K ﹤0.01% 1476
2022
Q4 		$1.55M Sell
151,000
-30,200
-17% -$533K 0.01% 1017
2022
Q3 		$3.3M Buy
181,200
+79,900
+79% +$3.46M 0.03% 686
2022
Q2 		$5.21M Sell
101,300
-170,400
-63% -$8.83M 0.05% 503
2022
Q1 		$20M Buy
271,700
+259,200
+2,074% +$23.1M 0.16% 169
2021
Q4 		$1.79M Sell
12,500
-1,900
-13% -$326K 0.01% 1081
2021
Q3 		$2.99M Buy
14,400
+4,200
+41% +$926K 0.02% 769
2021
Q2 		$2.17M Buy
+10,200
New +$1.87M 0.02% 909

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s NVAX Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of Novavax (NVAX) in Q1 2025, closing a stake of 287,804 shares — an estimated $2.38M sold.

Capital Fund Management (CFM) first reported a position in NVAX in Q4 2015 and held it in 8 quarters. The position peaked at $13.2M in Q2 2021. 245 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 287,804 Novavax shares in Q1 2025, an estimated $2.38M.
  • Capital Fund Management (CFM) first reported a position in Novavax in Q4 2015 and held it in 8 quarters.
  • Capital Fund Management (CFM)'s Novavax position peaked at $13.2M in Q2 2021.
  • 245 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.